Physician profile
Mark E Williams
NPI 1710971866
$9,060.38
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.76 · 2020: $66.54 · 2021: $57.78 · 2022: $333 · 2023: $272 · 2024: $8,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,002 · Travel and Lodging: $860 · Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,001.66 |
| Travel and Lodging | $859.76 |
| Food and Beverage | $659.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,034.86 | 2024 | |
| Baxter Healthcare | $408.05 | 2021-2024 | Floseal, Perclot, Tisseel |
| Novo Nordisk INC | $78.78 | 2023-2024 | Wegovy |
| Ethicon US, LLC | $77.02 | 2019-2024 | Surgicel Nu-Knit, Linx Reflux Management System |
| Tela Bio, INC. | $69.85 | 2019-2024 | Ovitex 2s |
| Smith+Nephew, INC. | $47.22 | 2023-2024 | Collagenase Santyl |
| Davol INC. | $46.17 | 2021-2023 | Phasix Mesh |
| Innocoll Pharmaceuticals Limited | $41.76 | 2022 | |
| Stryker Corporation | $40.71 | 2020 | |
| Urovant Sciences INC | $37.20 | 2022 | |
| Nevro Corp. | $27.67 | 2024 | Senza |
| Merck Sharp & Dohme LLC | $27.35 | 2019-2020 | |
| Integra Lifesciences Corporation | $19.70 | 2022 | |
| Kerecis Limited | $19.42 | 2022 | |
| Convatec INC. | $18.31 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $16.95 | 2022 | |
| Pfizer INC. | $13.71 | 2022 | |
| Acell, INC. | $12.84 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.88 | 2021 | |
| Mallinckrodt Enterprises LLC | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.